To systematically investigate the functional contribution of the conserved 128 MLL-interaction partners to MLL-fusion-dependent leukemia, we devised a shRNA screen in the human MLL-AF9-expressing AML cell line MOLM-13. This evidence concerns the gene KMT2A and acute myeloid leukemia.